About TB Vaccines
TB Vaccines are the vaccinations which are given for the prevention of tuberculosis. TB vaccines are commonly known as Bacillus Calmette-Guerin (BCG) vaccines These vaccines gives immunity to the human body to defense against the tuberculosis. Tuberculosis kills more people in the world than any other infection. Each year about 10 million people are infected with TB and about 1.8 million die. Mycobacterium tuberculosis is the bacteria that causes tuberculosis (TB). Lung tissue is the primary target of the infection. Because the bacterium is so harmful, it is typical to cough up both mucus and blood. A severe, frequently fatal form of TB known as "military" TB, which affects many different regions of the body, including the lining of the brain, is more likely to affect children under the age of five (meninges). TB is incredibly contagious and is spread by just chatting, coughing, and sneezing. Many infected persons don't immediately become ill; instead, the germs stay dormant, reactivating years, even decades, later. Lung disease and the recognizable cough start at that point. TB vaccines not only counter the TB virus but also prevent it from spreading.
|Unit||Value (USD Million)|
The market for TB Vaccines is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as product innovation and using various marketing strategies to gain a higher market share. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global TB Vaccines market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Merck (United States), Serum Institute of India Pvt. (India), Sanofi (France), Biofabri (Spain), Intervax Ltd (Canada), AJ Biologics (Malaysia), Japan BCG Lab (Japan), Biomed Lublin (Poland), Microgen (Germany) and GreenSignal Bio Pharma Private Limited (India) are some of the key players that are part of study coverage.
AMA Research has segmented the market of Global TB Vaccines market by Type (Attenuated and Booster), Application (Hospitals, Clinical Labs and Pharmaceuticals) and Region.
On the basis of geography, the market of TB Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the TB Vaccines market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Age Group, the sub-segment i.e. Pediatric will boost the TB Vaccines market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Technological Penetration in Pharmaceutical Industry and Innovation of Highly Effective BCG Vaccines for Tuberculosis
Market Growth Drivers:
Rising Cases of Tuberculosis in Infant and Children and Government Concern About Spreading of TB Virus
Low Penetration in Rural Area, Government Regulations Associated with TB Vaccines, Low Tuberculosis Rate in Developing Regions and Other vaccinations as a Substitute Available in Market
Side Effects and Other Health Issues Associated with TB Vaccines
Rising Growth in Healthcare Infrastructure
Market Leaders and their expansionary development strategies
On 14 July 2021, Spanish biopharmaceutical company Biofabri and IAVI announced their intention to partner on efficacy trials of the tuberculosis (TB) vaccine candidate MTBVAC. The candidate, designed by the Spanish researcher Dr. Carlos Martin from the University of Zaragoza, was in-licensed and is being manufactured and developed by Biofabri, a subsidiary of the Zendal Group, in collaboration with University of Zaragoza, IAVI, and Europe-based Tuberculosis Vaccine Initiative (TBVI).
The formulation of international requirements for the manufacture and control of BCG vaccine was first considered by the WHO Expert Committee on Biological Standardization in its thirteenth report. In its fourteenth report, the Committee requested WHO to make arrangements as soon as possible for the formulation of such requirements. These requirements were approved by the WHO Expert Committee on Biological Standardization at its eighteenth meeting and appeared as Annex 1 to its report.
Key Target AudienceTB Vaccines Manufacturers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.